Type I interferon signaling, regulation and gene stimulation in chronic virus infection

被引:96
作者
Lukhele, Sabelo [1 ]
Boukhaled, Giselle M. [1 ]
Brooks, David G. [1 ,2 ]
机构
[1] Univ Hlth Network, Tumor Immunotherapy Program, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Interferon; Chronic virus infection; Immune response; T cell; Innate immunity; Adaptive immunity; Exhaustion; Interferon regulatory factor; IRF; Interferon stimulatory gene; IS G; CD8(+) T-CELLS; NF-KAPPA-B; ANTIGEN-PRESENTING CELLS; CYTOSOLIC DNA SENSOR; HEPATITIS-C VIRUS; SIV INFECTION; IFN-BETA; HIV-1; INFECTION; DENDRITIC CELLS; TRYPTOPHAN CATABOLITES;
D O I
10.1016/j.smim.2019.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type I Interferons (IFN-I) mediate numerous immune interactions during viral infections, from the establishment of an antiviral state to invoking and regulating innate and adaptive immune cells that eliminate infection. While continuous IFN-I signaling plays critical roles in limiting virus replication during both acute and chronic infections, sustained IFN-I signaling also leads to chronic immune activation, inflammation and, consequently, immune exhaustion and dysfunction. Thus, an understanding of the balance between the desirable and deleterious effects of chronic IFN-I signaling will inform our quest for IFN-based therapies for chronic viral infections as well as other chronic diseases, including cancer. As such the factors involved in induction, propagation and regulation of IFN-I signaling, from the initial sensing of viral nucleotides within the cell to regulatory downstream signaling factors and resulting IFN-stimulated genes (ISGs) have received significant research attention. This review summarizes recent work on IFN-I signaling in chronic infections, and provides an update on therapeutic approaches being considered to counter such infections.
引用
收藏
页数:15
相关论文
共 221 条
[1]   Gene therapy with plasmids encoding IFN-β or IFN-α14 confers long-term resistance to HIV-1 in humanized mice [J].
Abraham, Sojan ;
Choi, Jang-Gi ;
Ortega, Nora M. ;
Zhang, Junli ;
Shankar, Premlata ;
Swamy, N. Manjunath .
ONCOTARGET, 2016, 7 (48) :78412-78420
[2]   Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection [J].
Aguirre, Sebastian ;
Luthra, Priya ;
Sanchez-Aparicio, Maria T. ;
Maestre, Ana M. ;
Patel, Jenish ;
Lamothe, Francise ;
Fredericks, Anthony C. ;
Tripathi, Shashank ;
Zhu, Tongtong ;
Pintado-Silva, Jessica ;
Webb, Laurence G. ;
Bernal-Rubio, Dabeiba ;
Solovyov, Alexander ;
Greenbaum, Benjamin ;
Simon, Viviana ;
Basler, Christopher F. ;
Mulder, Lubbertus C. F. ;
Garcia-Sastre, Adolfo ;
Fernandez-Sesma, Ana .
NATURE MICROBIOLOGY, 2017, 2 (05)
[3]  
[Anonymous], VIRUSES
[4]   Genetic control directed toward spontaneous IFN-α/IFN-β responses and downstream IFN-γ expression influences the pathogenesis of a murine psoriasis-like skin disease [J].
Arakura, Fuyuko ;
Hida, Shigeaki ;
Ichikawa, Eri ;
Yajima, Chihiro ;
Nakajima, Shinsuke ;
Saida, Toshiaki ;
Taki, Shinsuke .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :3249-3257
[5]   Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration [J].
Azzoni, Livio ;
Foulkes, Andrea S. ;
Papasavvas, Emmanouil ;
Mexas, Angela M. ;
Lynn, Kenneth M. ;
Mounzer, Karam ;
Tebas, Pablo ;
Jacobson, Jeffrey M. ;
Frank, Ian ;
Busch, Michael P. ;
Deeks, Steven G. ;
Carrington, Mary ;
O'Doherty, Una ;
Kostman, Jay ;
Montaner, Luis J. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (02) :213-222
[6]   BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrest [J].
Bai, Li-Yuan ;
Chiu, Chang-Fang ;
Kapuriya, Naval P. ;
Shieh, Tzong-Ming ;
Tsai, Yu-Chen ;
Wu, Chia-Yung ;
Sargeant, Aaron M. ;
Weng, Jing-Ru .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 :287-296
[7]   IFITM-Family Proteins: The Cell's First Line of Antiviral Defense [J].
Bailey, Charles C. ;
Zhong, Guocai ;
Huang, I-Chueh ;
Farzan, Michael .
ANNUAL REVIEW OF VIROLOGY, VOL 1, 2014, 1 :261-283
[8]   Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade [J].
Benci, Joseph L. ;
Xu, Bihui ;
Qiu, Yu ;
Wu, Tony J. ;
Dada, Hannah ;
Twyman-Saint Victor, Christina ;
Cucolo, Lisa ;
Lee, David S. M. ;
Pauken, Kristen E. ;
Huang, Alexander C. ;
Gangadhar, Tara C. ;
Amaravadi, Ravi K. ;
Schuchter, Lynn M. ;
Feldman, Michael D. ;
Ishwaran, Hemant ;
Vonderheide, Robert H. ;
Maity, Amit ;
Wherry, E. John ;
Minn, Andy J. .
CELL, 2016, 167 (06) :1540-+
[9]   PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: Restricted expression of type I interferon receptor by CCR5-expressing leukocytes [J].
Boasso, Adriano ;
Hardy, Andrew W. ;
Landay, Alan L. ;
Martinson, Jeffrey L. ;
Anderson, Stephanie A. ;
Dolan, Matthew J. ;
Clerici, Mario ;
Shearer, Gene M. .
CLINICAL IMMUNOLOGY, 2008, 129 (01) :132-144
[10]   TBK1: A key regulator and potential treatment target for interferon positive Sjogren's syndrome, systemic lupus erythematosus and systemic sclerosis [J].
Bodewes, Iris L. A. ;
Huijser, Erika ;
van Helden-Meeuwsen, Cornelia G. ;
Tas, Liselotte ;
Huizinga, Ruth ;
Dalm, Virgil A. S. H. ;
van Hagen, P. Martin ;
Groot, Noortje ;
Kamphuis, Sylvia ;
van Daele, Paul L. A. ;
Versnel, Marjan A. .
JOURNAL OF AUTOIMMUNITY, 2018, 91 :97-102